India, Sept. 8 -- Russia's experimental cancer vaccine has passed preclinical testing, showing both safety and high effectiveness, the country's news agency TASS has reported, citing the head of the Federal Medical and Biological Agency (FMBA).

Veronika Skvortsova, the head of the Federal Medical and Biological Agency (FMBA), said at the Eastern Economic Forum (EEF) that research on the vaccine has been underway for several years, with the past three years devoted to mandatory preclinical studies.

"The vaccine is now ready for use; we are awaiting official approval," she said, according to the Russian news agency.

The FMBA chief stressed that the preclinical results confirmed the drug's safety, even after repeated doses, and demonstrat...